Michael E Cox
Overview
Explore the profile of Michael E Cox including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eltit F, Wang Q, Jung N, Munshan S, Xie D, Xu S, et al.
JBMR Plus
. 2024 Sep;
8(10):ziae091.
PMID: 39224570
Bone metastases are the most severe and prevalent consequences of prostate cancer (PC), affecting more than 80% of patients with advanced PC. PCBMs generate pain, pathological fractures, and paralysis. As...
2.
Ruzanov P, Evdokimova V, Pachva M, Minkovich A, Zhang Z, Langman S, et al.
J Clin Invest
. 2024 Mar;
134(9).
PMID: 38530366
Aberrant expression of the E26 transformation-specific (ETS) transcription factors characterizes numerous human malignancies. Many of these proteins, including EWS:FLI1 and EWS:ERG fusions in Ewing sarcoma (EwS) and TMPRSS2:ERG in prostate...
3.
Cunningham A, Brown M, Dresselhuis J, Robinson N, Hervie K, Cox M, et al.
Biology (Basel)
. 2023 Jul;
12(7).
PMID: 37508338
In cancer cells, inhibition of integrin-linked kinase (ILK) increases centrosome declustering causing mitotic arrest and cell death. Yet, not all cancer cells are susceptible to anti-ILK treatment alone. We investigate...
4.
Eltit F, Robinson N, Yu P, Pandey M, Lozada J, Guo Y, et al.
Adv Exp Med Biol
. 2023 Apr;
1408:291-308.
PMID: 37093434
Prostate-specific membrane antigen (PSMA) is expressed in epithelial cells of the prostate gland and is strongly upregulated in prostatic adenocarcinoma, with elevated expression correlating with metastasis, progression, and androgen independence....
5.
Pandey M, Cuddihy G, Gordon J, Cox M, Wasan K
Pharmaceutics
. 2021 Sep;
13(9).
PMID: 34575583
There have been several studies that have linked elevated scavenger receptor class b type 1 (SR-B1) expression and activity to the development and progression of castration-resistant prostate cancer (CRPC). SR-B1...
6.
Eltit F, Noble J, Sharma M, Benam N, Haegert A, Bell R, et al.
Acta Biomater
. 2021 Jun;
131:581-594.
PMID: 34192572
Adverse local tissue reactions (ALTRs) are a prominent cause of hip implant failure. ALTRs are characterized by aseptic necrosis and leukocyte infiltration of synovial tissue. The prevalence of ALTRs in...
7.
Eltit F, Mohammad N, Medina I, Haegert A, Duncan C, Garbuz D, et al.
J Orthop Res
. 2021 Jan;
39(12):2581-2594.
PMID: 33506972
Hip implants are a successful solution for osteoarthritis; however, some individuals with metal-on-metal (MoM) and metal-on-polyethylene (MoP) prosthetics develop adverse local tissue reactions (ALTRs). While MoM and MoP ALTRs are...
8.
Gordon J, Noble J, Midha A, Derakhshan F, Wang G, Adomat H, et al.
Cancer Res
. 2019 May;
79(13):3320-3331.
PMID: 31064850
Aberrant cholesterol metabolism is increasingly appreciated to be essential for prostate cancer initiation and progression. Transcript expression of the high-density lipoprotein-cholesterol receptor scavenger receptor B1 (SR-B1) is elevated in primary...
9.
Hsing M, Wang Y, Rennie P, Cox M, Cherkasov A
Med Res Rev
. 2019 Mar;
40(1):413-430.
PMID: 30927317
The ETS family of proteins consists of 28 transcription factors, many of which have been implicated in development and progression of a variety of cancers. While one family member, ERG,...
10.
Esmaeilsabzali H, Payer R, Guo Y, Cox M, Parameswaran A, Beischlag T, et al.
Biomicrofluidics
. 2019 Mar;
13(1):014110.
PMID: 30867880
Efforts to further improve the clinical management of prostate cancer (PCa) are hindered by delays in diagnosis of tumours and treatment deficiencies, as well as inaccurate prognoses that lead to...